Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › Washington
Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in Washington
3 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in Washington.
Cities in Washington
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Clinical Study Site, Seattle
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT06858579A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
- Fred Hutchinson Cancer Center, Seattle
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Aug 14, 2026 · NCT07304154A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- University of Washington, Seattle
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT06798012From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.